Opportunity Information: Apply for RFA RM 21 003

This funding opportunity (RFA-RM-21-003) is a National Institutes of Health (NIH) cooperative agreement (U24; clinical trial not allowed) under CFDA 93.310 that supports the creation or designation of one or more Microbiome and Metagenomics Centers (MMCs) to participate in the Nutrition for Precision Health initiative, which is powered by the All of Us Research Program. The central purpose is to add a dedicated, consortium-scale capability for generating and analyzing microbiome-related data that can be integrated with the broader Nutrition for Precision Health study data. In practical terms, the MMC is meant to function as a core resource for the consortium, providing standardized laboratory and analytical workflows so microbiome results are comparable across participants and usable for downstream precision nutrition research.

The scientific and operational focus of the MMC is analysis of stool specimens collected as part of the Nutrition for Precision Health study. The FOA specifically highlights three major types of work: microbiome profiling, metagenomics, and metatranscriptomics. Microbiome work typically refers to characterizing microbial communities present in the samples, while metagenomics focuses on sequencing and analyzing the collective genetic material of those communities to infer functional potential (for example, metabolic pathways that could influence nutrient processing). Metatranscriptomics extends this further by examining RNA expression patterns to understand which microbial genes are actively being expressed at the time of sampling, providing a more dynamic view of microbiome activity that may relate to dietary intake, host metabolism, and other health-related phenotypes captured in the parent study.

Because the award mechanism is a cooperative agreement, the expectation is not simply to run an isolated lab service, but to operate as an active partner within an NIH-led consortium structure. Cooperative agreements usually involve substantial programmatic involvement from NIH, meaning awardees often coordinate closely with NIH staff and other consortium components on issues like protocol harmonization, quality control standards, data pipelines, timelines, reporting, and integration with other study cores. The “clinical trial not allowed” designation clarifies that the MMC’s work should not be structured as an interventional clinical trial; rather, it is positioned as a research support and data generation/analysis center contributing to an ongoing observational or consortium-driven study framework.

Eligibility is broad and includes many common domestic applicant categories: state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized tribal governments; tribal organizations other than federally recognized tribal governments; public housing authorities/Indian housing authorities; nonprofits with and without 501(c)(3) status (other than institutions of higher education); for-profit organizations (other than small businesses); and small businesses. The FOA also explicitly calls out additional eligible applicant types such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal agencies, Indian/Native American Tribal Governments (other than federally recognized), and U.S. territories or possessions. At the same time, it states that non-domestic (non-U.S.) entities (foreign organizations/foreign institutions) are not eligible to apply as applicant organizations. However, non-domestic components of U.S. organizations may participate, and foreign components (as defined in the NIH Grants Policy Statement) are allowed, which generally means a U.S. applicant can include certain foreign activities or collaborations if properly justified and consistent with NIH policy.

Key administrative details included in the source information are that NIH is the sponsoring agency; the opportunity category is discretionary; the award instrument is a cooperative agreement (U24); and the original application closing date listed is April 6, 2021 (with a creation date of January 21, 2021). The award ceiling and expected number of awards are not specified in the provided text. Overall, the FOA is aimed at building a centralized, high-quality microbiome and multi-omics capability for stool samples that can support the Nutrition for Precision Health consortium’s broader goal of understanding how nutrition-related factors interact with biology to enable more precise, individualized approaches to health.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Nutrition for Precision Health, powered by the All of Us Research Program: Microbiome and Metagenomics Center (U24 Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.310.
  • This funding opportunity was created on 2021-01-21.
  • Applicants must submit their applications by 2021-04-06. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA RM 21 003

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

Previous opportunity: Established Program to Stimulate Competitive Research (DOE ESPCoR) Implementation Grants

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA RM 21 003

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA RM 21 003) also looked into and applied for these:

Funding Opportunity
Nutrition for Precision Health, powered by the All of Us Research Program: Artificial Intelligence for Multimodal Data Modeling and Bioinformatics Center (U54 Clinical Trial Not Allowed) Apply for RFA RM 21 001

Funding Number: RFA RM 21 001
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed) Apply for PAR 21 106

Funding Number: PAR 21 106
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Pre-Clinical Research (R44 Clinical Trial Not Allowed) Apply for PAR 21 114

Funding Number: PAR 21 114
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIA MSTEM: Advancing Diversity in Aging Research through Undergraduate Education (R25 - Independent Clinical Trial Not Allowed) Apply for PAR 20 317

Funding Number: PAR 20 317
Agency: National Institutes of Health
Category: Health
Funding Amount: $375,000
The Cellular Scale Connectome in Aging and Alzheimers Disease (U01 Clinical Trial Not Allowed) Apply for RFA AG 22 008

Funding Number: RFA AG 22 008
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Limited Competition for the Continuation of Multisite Clinical Trial Data Coordinating Center (Collaborative U24 Clinical Trial Optional) Apply for PAR 21 116

Funding Number: PAR 21 116
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Limited Competition for the Continuation or Revision of Multisite Clinical Trial Clinical Coordinating Center (Collaborative UH3 Clinical Trial Optional) Apply for PAR 21 117

Funding Number: PAR 21 117
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care (R21/R33 - Clinical Trial Optional) Apply for PA 21 158

Funding Number: PA 21 158
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent
Screening for Conditions by Electronic Nose Technology (SCENT) (U01 Clinical Trial Optional) Apply for RFA TR 21 009

Funding Number: RFA TR 21 009
Agency: National Institutes of Health
Category: Health
Funding Amount: $650,000
Early-Phase Clinical Trials of Novel Interventions to Prevent, Delay, or Treat Aging-Related Conditions by Targeting Aging-Related Mechanisms (U01 Clinical Trial Required) Apply for RFA AG 22 011

Funding Number: RFA AG 22 011
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trial Not Allowed) Apply for RFA AA 21 002

Funding Number: RFA AA 21 002
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000
SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trial Not Allowed) Apply for RFA AA 21 004

Funding Number: RFA AA 21 004
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trial Not Allowed) Apply for RFA AA 21 003

Funding Number: RFA AA 21 003
Agency: National Institutes of Health
Category: Health
Funding Amount: $50,000
Expert-Driven Small Projects to Strengthen Gabriella Miller Kids First Discovery (R03 Clinical Trial Not Allowed) Apply for RFA RM 21 011

Funding Number: RFA RM 21 011
Agency: National Institutes of Health
Category: Health
Funding Amount: $100,000
NIDCR Predoctoral to Postdoctoral Transition Award for a Diverse Dental, Oral and Craniofacial Research Workforce (F99/K00 Independent Clinical Trial Not Allowed) Apply for PAR 21 060

Funding Number: PAR 21 060
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Limited Competition: Basic Instrumentation Grant (BIG) Program (S10 Clinical Trial Not Allowed) Apply for PAR 21 125

Funding Number: PAR 21 125
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000
Human Immunology Project Consortium (U19 Clinical Trial Optional) Apply for RFA AI 20 079

Funding Number: RFA AI 20 079
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,500,000
Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care (R21/R33 - Clinical Trial Optional) Apply for PA 21 164

Funding Number: PA 21 164
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent
NEI Translational Research Program (TRP) on Therapy for Visual Disorders (R24 Clinical Trial Optional) Apply for PAR 20 319

Funding Number: PAR 20 319
Agency: National Institutes of Health
Category: Health
Funding Amount: $15,000,000
Basic Research to Inform Vaccine and Therapeutic Development for Non-Polio Human Enteroviruses (NPEV) (R01 Clinical Trial Not Allowed) Apply for RFA AI 21 006

Funding Number: RFA AI 21 006
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA RM 21 003", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: